- Racial disparities in immune-related adverse events of immun... 2021-02-22
- Chronic myeloid leukemia-from the Philadelphia chromosome to... 2021-02-22
- Pancreatic cancer in the era of COVID-19 pandemic: Which one... 2021-02-22
- New Year's greeting and overview of World Journal of Clinica... 2021-02-22
- Metastatic hormone-sensitive prostate cancer: How should it ... 2021-02-22
World Journal of Clinical Oncology (WJCO, World J Clin Oncol) is a high-quality, online, open-access, single-blind peer-reviewed journal published by the Baishideng Publishing Group. WJCO accepts both solicited and unsolicited manuscripts. Articles published in WJCO are high-quality, basic and clinical, influential research articles by established academic authors as well as new researchers. The paramount objective of WJCO is to showcase and promote distinguished research in the field of oncology, to help advance development of this field. The types of articles published in WJCO include Editorial, Opinion Review, Frontier, Review, Minireview, Basic Study, Clinical Research, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. Submit here >>
- Hiten RH Patel, BM BCh, BSc, FRCS, PhD, Professor, Surgical Oncologist, (E-mail: hrhpatel@hotmail.com) Department of Urology, University Hospital North Norway (UNN), Tromso 9038, Norway
- Stephen Safe, PhD, Professor, (E-mail: ssafe@cvm.tamu.edu) Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77845, United States



